Derived from a protein in the stomach, BPC-157 is celebrated for its ability to promote gut health, improve joint and muscle healing, and reduce inflammation
The Promising Findings GHK-Cu has the most robust human evidence, particularly for topical skincare applications BPC-157 shows impressive results in animal studies for wound healing, collagen production, and tissue repair Peptides generally have favorable safety profiles in the studies that exist The mechanisms make biological sense: peptides do play real roles in healing The Limitations Most studies on BPC-157 and TB-500 are animal-based, not human There are no standardized dosing protocols for most injectable peptides Long-term safety data in humans is limited Many peptides are not FDA-approved for cosmetic or surgical recovery purposes Quality control varies widely between compounding pharmacies Important: Many injectable peptides are classified as research compounds and are not approved for human use outside of clinical trials

Overexpression or mutation of PTP1B has been observed in breast cancer cells, suggesting its role in promoting oncogenic signalling and tumour development (62)
Carter, R., Mouralidarane, A., Ray, S., Soeda, J
Material Safety Data Sheet: Coming Soon